CSIMarket


Applied Biosciences Corp.  (FRRX)
Other Ticker:  
 


 

Applied Biosciences Corp.

FRRX's Financial Statements and Analysis



Applied Biosciences Corp. narrowed third quarter of 2020 net loss per share of $-0.10 compare to net loss per share of $-0.16 recorded in the same quarter a year ago a decrease compare to $-0.06 realized in previous quarter.


third quarter of 2020
Earnings Per Share Revenues
$ -0.1 $  0 Mill
$+0.06     Unch.     -58.95 %



Applied Biosciences's Revenue fell by -58.95 % in third quarter of 2020 (Dec 31 2019) year on year, to $0 million and declined by -30.58 % sequentially.


Applied Biosciences is

More on FRRX's Income Statement



Applied Biosciences's in thethird quarter of 2020 recorded net loss of $-0.145 million, an improvement compare to net loss of $-1.892 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-0.155 million realized in previous quarter.

More on FRRX's Growth

Applied Biosciences Inventories
Inventories grew by 44.82 % to $0 million from III. Quarter a year ago, sequentially inventories fell by -3.92 %. In Dec 31 2019 company's net cash and cash equivalents decreased by $0 million


Applied Biosciences Corp. does not pay out common stock dividend.

In trailing twelve-month period Applied Biosciences Corp. payed $ -0.07 cash per share, on a free-cash flow basis .

Book value fell by -80.84 % sequentially to $0.02 per share, -33.99% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -0.13 per share from $ -0.06.

Company issued 0.18 million shares or 1.36 % in Dec 31 2019.


More on FRRX's Dividends

 Market Capitalization (Millions) -
 Shares Outstanding (Millions) 14
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1




Applied Biosciences Corp. does not pay out common stock dividend.

In trailing twelve-month period Applied Biosciences Corp. had negative $ -0.07 cash flow per share, on a free-cash flow basis .

Book value fell by -80.84 % sequentially to $0.02 per share, -33.99% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -0.13 per share from $ -0.06.

Company issued 0.18 million shares or 1.36 % in Dec 31 2019.


More on FRRX's Balance Sheets

 Market Capitalization (Millions) -
 Shares Outstanding (Millions) 14
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1
   



Date modified: 2023-03-22T03:17:09+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com